SG10201607176TA - Methods And Compositions For Treatment Of Retinal Degeneration - Google Patents

Methods And Compositions For Treatment Of Retinal Degeneration

Info

Publication number
SG10201607176TA
SG10201607176TA SG10201607176TA SG10201607176TA SG10201607176TA SG 10201607176T A SG10201607176T A SG 10201607176TA SG 10201607176T A SG10201607176T A SG 10201607176TA SG 10201607176T A SG10201607176T A SG 10201607176TA SG 10201607176T A SG10201607176T A SG 10201607176TA
Authority
SG
Singapore
Prior art keywords
compositions
treatment
methods
retinal degeneration
retinal
Prior art date
Application number
SG10201607176TA
Other languages
English (en)
Inventor
Casey C Case
Toru Kawanishi
Kuno Noriyuki
Original Assignee
Sanbio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanbio Inc filed Critical Sanbio Inc
Publication of SG10201607176TA publication Critical patent/SG10201607176TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG10201607176TA 2012-10-09 2013-03-13 Methods And Compositions For Treatment Of Retinal Degeneration SG10201607176TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261711665P 2012-10-09 2012-10-09

Publications (1)

Publication Number Publication Date
SG10201607176TA true SG10201607176TA (en) 2016-10-28

Family

ID=48040427

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201502753YA SG11201502753YA (en) 2012-10-09 2013-03-13 Methods and compositions for treatment of retinal degeneration
SG10201607176TA SG10201607176TA (en) 2012-10-09 2013-03-13 Methods And Compositions For Treatment Of Retinal Degeneration

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201502753YA SG11201502753YA (en) 2012-10-09 2013-03-13 Methods and compositions for treatment of retinal degeneration

Country Status (11)

Country Link
US (2) US9326999B2 (zh)
EP (1) EP2906293B1 (zh)
JP (2) JP6267713B2 (zh)
KR (2) KR101906756B1 (zh)
CN (1) CN104797264A (zh)
AU (2) AU2013330433B2 (zh)
CA (1) CA2885414C (zh)
HK (1) HK1208371A1 (zh)
IL (1) IL237772B (zh)
SG (2) SG11201502753YA (zh)
WO (1) WO2014058464A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101906756B1 (ko) 2012-10-09 2018-12-05 산바이오 인코포레이티드 망막 변성의 치료 방법 및 치료용 조성물
US10144778B2 (en) 2014-03-12 2018-12-04 Yeda Research And Development Co. Ltd Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
US10618963B2 (en) 2014-03-12 2020-04-14 Yeda Research And Development Co. Ltd Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
US10519237B2 (en) 2014-03-12 2019-12-31 Yeda Research And Development Co. Ltd Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
RU2682619C2 (ru) 2014-07-31 2019-03-19 Юнилин, Бвба Способ и установка для изготовления изделия для покрытия пола и получаемое в результате изделие для покрытия пола
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
CA3047329A1 (en) 2016-12-28 2018-07-05 Sanbio, Inc. Cell delivery system and methods of operation thereof
WO2018170239A1 (en) 2017-03-15 2018-09-20 The Regents Of The University Of California Methods of treating lysosomal disorders
CN107519491B (zh) * 2017-09-04 2020-08-25 无锡市人民医院 Copb2抑制剂的用途
WO2020210218A1 (en) * 2019-04-12 2020-10-15 The Regents Of The University Of California Methods for treating inherited eye defects

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002247847A1 (en) * 2001-04-09 2002-10-21 Lorantis Limited Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
JP3886346B2 (ja) 2001-06-22 2007-02-28 サンバイオ，インコーポレイティド 骨髄間質細胞由来Ｓｃｈｗａｎｎ細胞を含む神経再生用医薬組成物
JP2004537314A (ja) * 2001-07-25 2004-12-16 ロランティス リミテッド ノッチシグナル伝達モジュレーターを検出する方法
AU2003207064B2 (en) * 2002-02-06 2006-07-13 Sanbio, Inc. Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring Notch gene
GB0300428D0 (en) * 2003-01-09 2003-02-05 Lorantis Ltd Medical treatment
DK1737950T3 (da) 2004-04-12 2011-12-05 Sanbio Inc Celler, der udviser neuronal-progenitorcelle-karakteristika
CA2599971C (en) 2005-03-07 2012-12-18 Sanbio Inc. Use of neuronal precursor cells for treatment of central nervous system lesions
US10494607B2 (en) * 2007-02-12 2019-12-03 Celularity, Inc. CD34+,CD45−placental stem cell-enriched cell populations
WO2008102460A1 (en) 2007-02-23 2008-08-28 Sanbio Inc. Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury
CN101801396B (zh) * 2007-08-15 2013-10-30 桑比欧公司 治疗神经变性的方法和组合物
ES2551356T3 (es) 2007-12-03 2015-11-18 Sanbio, Inc. Métodos y composiciones para modular la diferenciación de células pluripotenciales
WO2009073178A1 (en) 2007-12-03 2009-06-11 Sanbio, Inc. Extracellular matrix from pluripotent cells
JP5710265B2 (ja) * 2007-12-06 2015-04-30 アンセルム（アンスチチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル） 網膜変性疾患の治療のための栄養因子
AU2009241736B2 (en) * 2008-04-30 2014-05-08 Sanbio, Inc. Neural regenerating cells with alterations in DNA methylation
WO2010002943A1 (en) 2008-07-01 2010-01-07 Lsi Corporation Methods and apparatus for interfacing between a flash memory controller and a flash memory array
ES2535614T3 (es) * 2008-07-08 2015-05-13 Oncomed Pharmaceuticals, Inc. Agentes de unión a Notch y antagonistas y métodos de uso de los mismos
WO2010144696A1 (en) * 2009-06-11 2010-12-16 Burnham Institute For Medical Research Directed differentiation of stem cells
JP5852969B2 (ja) * 2010-02-26 2016-02-03 コーネル ユニヴァーシティー 人工網膜
HUE054517T2 (hu) * 2010-07-23 2021-09-28 Astellas Inst For Regenerative Medicine Eljárások sejtek ritka alpopulációinak detektálására és nagymértékben tisztított sejtkészítmények
US8883502B2 (en) * 2010-09-09 2014-11-11 The Regents Of The University Of California Expandable cell source of neuronal stem cell populations and methods for obtaining and using them
US8785190B2 (en) 2011-04-06 2014-07-22 Sanbio, Inc. Methods and compositions for modulating peripheral immune function
US20120263681A1 (en) 2011-04-12 2012-10-18 Fujifilm Corporation Composition comprising cell and biocompatible polymer
JP6306506B2 (ja) 2011-08-19 2018-04-04 サンバイオ，インコーポレイティド 神経原生及びグリア原生因子及びそれらについてのアッセイ
WO2013112917A1 (en) 2012-01-27 2013-08-01 Sanbio, Inc. Methods and compositions for modulating angiogenesis and vasculogenesis
EP2849766B1 (en) 2012-05-16 2019-03-06 SanBio, Inc. Cells for use in the treatment of brain injury
US20140219976A1 (en) 2012-10-09 2014-08-07 Sanbio, Inc. Methods and compositions for treatment of retinal degeneration
KR101906756B1 (ko) 2012-10-09 2018-12-05 산바이오 인코포레이티드 망막 변성의 치료 방법 및 치료용 조성물

Also Published As

Publication number Publication date
US20140099291A1 (en) 2014-04-10
JP2015533122A (ja) 2015-11-19
CA2885414A1 (en) 2014-04-17
EP2906293B1 (en) 2018-12-12
AU2013330433A1 (en) 2015-04-02
KR20170133515A (ko) 2017-12-05
CA2885414C (en) 2018-05-01
HK1208371A1 (zh) 2016-03-04
US9855299B2 (en) 2018-01-02
KR20150075082A (ko) 2015-07-02
CN104797264A (zh) 2015-07-22
US9326999B2 (en) 2016-05-03
EP2906293A1 (en) 2015-08-19
AU2016213752B2 (en) 2017-11-23
JP2016210813A (ja) 2016-12-15
AU2016213752A1 (en) 2016-08-25
AU2013330433B2 (en) 2016-06-16
IL237772A0 (en) 2015-05-31
SG11201502753YA (en) 2015-05-28
JP6267713B2 (ja) 2018-01-24
KR101906756B1 (ko) 2018-12-05
IL237772B (en) 2019-10-31
US20160271181A1 (en) 2016-09-22
WO2014058464A1 (en) 2014-04-17
JP6297648B2 (ja) 2018-03-20

Similar Documents

Publication Publication Date Title
IL260585B (en) Preparations and methods for the treatment of diseases related to the retina of the eye
HK1210502A1 (zh) 用於治療遺傳性病狀的方法和組合物
HK1210968A1 (zh) 用於眼部疾病和病症的組合物和治療
HK1208371A1 (zh) 用於治療視網膜變性的方法和組合物
EP2771030A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF PROTEINOPATHIES
PT2776567T (pt) Composições e métodos para o tratamento de citomegalovírus
SG2014008080A (en) Methods of treatment of retinal degeneration diseases
EP2819687A4 (en) COMPOSITIONS AND METHODS FOR TREATING PERIPHERAL VASCULAR DISEASE
DK3292875T3 (en) Compositions and methods for treating diseases
EP2691529A4 (en) METHOD AND COMPOSITIONS FOR TREATING BRAIN DISEASES
PL2814463T3 (pl) Okulistyczne kompozycje farmaceutyczne i sposoby ich wytwarzania i stosowania
IL234606A0 (en) Innovative methods and compounds for the treatment of diseases
EP2755668A4 (en) COMPOSITIONS OF HYR1 AND TREATMENT PROCEDURES THEREWITH
EP2670243A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLAUCOMA
EP2879495A4 (en) COMPOSITIONS AND METHODS OF TREATING NEUROPSYCHOLOGICAL DEFICIENCIES
EP2928456A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP2800568A4 (en) COMPOSITIONS, USE METHOD AND TREATMENT METHOD THEREFOR
EP2825184A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN
EP3003341A4 (en) Compositions and methods for treatment of retinal degenerative diseases
AU2012902296A0 (en) Compositions for Therapy and Methods of Treatment